Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

The COG rate of Daiichi Pharmaceutical Group has improved from what we saw in January when they were upwardly revised. What are the contributing factors?

April 26, 2017cog daiichi group January pharmaceutical rate revised saw

0

Posted

The COG rate of Daiichi Pharmaceutical Group has improved from what we saw in January when they were upwardly revised. What are the contributing factors?

1 Answer

0

Posted

A31.They have three factors: a lump-sum payment for Plavix, further effect of improved method of manufacturing on Levofloxacin, and efforts by spin-offed Daiichi Pharmatech to reduce cost rates.